ventricular assist device

(redirected from Heart assist device)
Also found in: Medical.

ventricular assist device:

see under heart, artificialheart, artificial,
external or surgically implanted mechanical device designed to replace a patient's diseased heart. The first one used on a human being, the Jarvik-7, was implanted (1982) in Barney Clark, who lived for 112 days; another patient, William Schroeder, lived 620
..... Click the link for more information.
References in periodicals archive ?
com) California Pacific offers the latest technology for treating heart failure, including Thoratec's HeartMate(R) LVAD -- an implanted mechanical circulatory heart assist device -- to persons with heart failure who do not qualify for a heart transplant (so-called "Destination Therapy").
The DeBakey VAD(TM) is 30mm x 76 mm, weighs 93 grams and is approximately 1/10th the size of portable heart assist devices already on the market.
ABIOMED also disclosed that it plans to expand its product offerings in the heart assist device market.
The Jarvik 2000 model with the behind-the-ear connector has supported more than 200 patients in Europe for DT, including the longest survival of any heart assist device patient in the world, 71/2 years.
The trial will randomize up to 350 study subjects to either the treatment group, in which patients receive the Jarvik 2000 intraventricular heart assist device, or the control group, which will receive the HeartMate II left ventricular assist device (LVAD), the most widely used FAD-approved LVAD for DT.
So it's a true heart assist device as opposed to a heart replacement device," Peters said.
Heart Assist Device to Become Widely Available to Patients With Severe Heart Failure
In the pivotal clinical study, the TAH-t had a bridge to transplant success rate of 79 percent (New England Journal of Medicine 2004; 351: 859-867), which is the highest success rate of any heart assist device in the world.
David is the first patient with chronic heart failure at any pediatric hospital to have his heart healed by using an intracorporeal mechanical heart assist device," said Dr.
Tucson, AZ, has received approval from Health Canada to market its implantable heart assist device, CardioWest Temporary Total Artificial Heart (TAH-t) for use in patients eligible for heart transplant who are at risk of imminent death from nonreversible biventricular failure.
We look forward to his contributions as we continue to pursue strategic partnerships and licensing agreements for our MRI-safe biomedical device technologies, and our investment in the MYOTECH MYO-VAD(TM), a next generation heart assist device.